Download PDF
Synthesis 2003(11): 1717-1721
DOI: 10.1055/s-2003-40876
PAPER
© Georg Thieme Verlag Stuttgart ˙ New York

Design and Combinatorial Synthesis of N-Acyl Iminodiacetic Acids as Bongkrekic Acid Analogues for the Inhibition of Adenine Nucleotide Translocase

Yazhong Pei*, Amy K. Carroll, Christen M. Anderson, Walter H. Moos, Soumitra S. Ghosh
MitoKor, Inc., 11494 Sorrento Valley Road, San Diego, CA 92121, USA
Fax: +1(858)5095700; e-Mail: peiy@mitokor.com;
Further Information

Publication History

Received 7 May 2003
Publication Date:
25 July 2003 (online)

    Permissions and Reprints All articles of this category

Abstract

The adenine nucleotide translocase (ANT) mediates ADP/ATP exchange in mitochondria and is also a critical component of the mitochondrial permeability transition (MPT) pore. Opening of this physiological pore has been implicated as a key step in initiating cell death, hence agents that prevent MPT pore opening may be of potential therapeutic value. The natural product bongkrekic acid is a potent ANT inhibitor that is reported to block MPT opening. We present the design and synthesis of N-acyl iminodiacetic acids as novel inhibitors of ANT-1, using bongkrekic acid as an initial lead. The identification of potent ANT-1 inhibitors from a primary binding assay and the preliminary structure-activity relationship based on these new leads are discussed.

Key words

bongkrekic acid - mitochondria - library design - combinatorial synthesis - N-acyl iminodiacetic acids

    References

  • 1 Brandolin G. Le Saux A. Trezeguet V. Lauquin GJM. Vignais PV. J. Bioenerg. Biomembr.  1993,  25:  459 
    Google Scholar
  • 2 Fiore C. Trezeguet V. Le Saux A. Roux P. Schwimmer C. Dianoux AC. Noel F. Lauquin GJ. Brandolin G. Vignais PV. Biochimie  1998,  80:  137 
    CrossrefGoogle Scholar
  • 3 Klingenberg M. Arch. Biochem. Biophys.  1989,  270:  1 
    Google Scholar
  • 4 Friberg H. Wieloch T. Biochimie  2002,  84:  241 
    CrossrefGoogle Scholar
  • 5 Halestrap AP. McStay GP. Clarke SJ. Biochimie  2002,  84:  153 
    CrossrefGoogle Scholar
  • 6 Crompton M. Barksby E. Johnson N. Capano M. Biochimie  2002,  84:  143 
    CrossrefGoogle Scholar
  • 7 Belzacq AS. Vieira HL. Kroemer G. Brenner C. Biochimie  2002,  84:  167 
    CrossrefGoogle Scholar
  • 8 Fiore C. Stubbs M. Pharmacol. Ther.  1979,  7:  329 
    CrossrefGoogle Scholar
  • 9 Green DR. Reed JC. Science  1998,  281:  1309 
    CrossrefGoogle Scholar
  • 10 Lijmbach GWM. Cox HC. Berends W. Tetrahedron  1969,  26:  5993 
    Google Scholar
  • 11 Corey EJ. Tramontano A. J. Am. Chem. Soc.  1984,  106:  462 
    CrossrefGoogle Scholar
  • 12 Lauquin GJ. Duplaa A.-M. Klein G. Rousseau A. Vignais PV. Biochemistry  1976,  15:  2323 
    CrossrefGoogle Scholar
  • 13 Scott BO. Siegmund AC. Marlowe CK. Pei Y. Spear KL. Mol. Diversity  1995,  1:  125 
    Google Scholar
  • 14 Pei Y. Houghten RA. Kiely JS. Tetrahedron Lett.  1997,  38:  3349 
    Google Scholar
  • 15 Meyers HV. Dilley GJ. Durgin TL. Powers TS. Winssinger NA. Zhu H. Pavia MR. Mol. Diversity  1995,  1:  13 
    Google Scholar
  • 16 Anderson CM, Davis RE, Clevenger W, Wiley SE, Miller SW, Szabo TR, Ghosh SS, Moos WH, Pei Y, and Carroll AK. inventors; PCT Int. Appl. WO  01/85944.  ; Chem. Abstr. 2001, 136,160
  • 17 Powel SJ. Medd SM. Runswick MJ. Walker JE. Biochemistry  1989,  28:  866 
    CrossrefGoogle Scholar